Difficulty: Medium
Average Score: 80%
Practice
Monitoring of a patient who is on a lipid-lowering drug includes:
Correct answer
B
Rationale
Monitoring lipid-lowering drugs (e.g., statins) involves a lipid profile (LDL focus) at 6-8 weeks post-start, then 6 weeks later, to assess efficacy (e.g., 30-50% LDL drop, ACC/AHA) and adjust dose. Total cholesterol every 6 months lacks specificity LDL drives decisions. CBC/CRP/ESR aren't routine liver enzymes (ALT/AST) are, but not listed. 'All' overstates lipid profile timing, per guidelines, makes B the choice.